Similarly, the pooled result from three datasets of PFS showed that decreased expression of PTEN also had an unfavorable prognostic value for PFS in NSCLC patients (HR = 0.48, 95% CI: 0.26–0.88, P = 0.018) (Figure 4). The gene discussed is PTEN; the disease is non-small cell lung carcinoma.